GLUL and Hyperammonemia: Given the therapeutic limitations of glutamine synthetase inhibition and NMDA receptor blockade, we assumed that lowering brain glutamate concentrations by inhibition of OAT-mediated transamination could be an alternative approach to minimize cerebral glutamate excitotoxicity in acute hyperammonemia.